Patient and Health Care Provider Perspectives on Potential Preventability of Hospital Admission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Qualitative Study

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Dhamane AD, Moretz C, Zhou Y, et al. COPD exacerbation frequency and its association with health care resource utilization and costs. Int J Chron Obstruct Pulmon Dis. 2015;10:2609–2618. doi:10.2147/COPD.S90148
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(7):502–506. doi:10.1513/pats.200701-001FM
   PubMedGoogle Scholar
• Soler-Cataluña JJ, Martínez-García MÁ, Serra PC. Multidimensional impact of COPD exacerbations. Arch Bronconeumol. 2010;46(Suppl 11):12–19. doi:10.1016/S0300-2896(10)70057-0
   PubMedGoogle Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Harries TH, Thornton H, Crichton S, Schofield P, Gilkes A, White PT. Hospital readmissions for COPD: a retrospective longitudinal study. NPJ Prim Care Respir Med. 2017;27(1):31. doi:10.1038/s41533-017-0028-8
   PubMed Web of Science ®Google Scholar
• Korpershoek YJG, Vervoort SCJM, Trappenburg JCA, Schuurmans MJ. Perceptions of patients with chronic obstructive pulmonary disease and their health care providers towards using mHealth for self-management of exacerbations: a qualitative study. BMC Health Serv Res. 2018;18(1):1. doi:10.1186/s12913-018-3545-4
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease - GOLD. GOLD 2022 global strategy for the diagnosis, management, and prevention of COPD; 2021. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed July 6, 2022.
   Google Scholar
• Schrijver J, Effing TW, Brusse-Keizer M, van der Palen J, van der Valk P, Lenferink A. Predictors of patient adherence to COPD self-management exacerbation action plans. Patient Educ Couns. 2021;104(1):163–170. doi:10.1016/j.pec.2020.06.015
   PubMed Web of Science ®Google Scholar
• Westbroek LF, Klijnsma M, Salomé P, et al. Reducing the number of hospitalization days for COPD: setting up a transmural-care pathway. Int J Chron Obstruct Pulmon Dis. 2020;15:2367–2377. doi:10.2147/COPD.S242914
   PubMed Web of Science ®Google Scholar
• Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18(9):1263–1278. doi:10.1007/s11136-009-9540-9
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24. doi:10.1080/08870449908407311
   Web of Science ®Google Scholar
• de Ridder D, Theunissen N. Beliefs about Medicine Questionnaire (BMQ) BMQ specific & BMQ general Dutch translation; 2003. Available from: https://meetinstrumentenzorg.nl/instrumenten/beliefs-about-medicine-questionnaire-bmq-bmq-specific-bmq-general/. Accessed July 6, 2022.
   Google Scholar
• van Gastel M, van Engelen E. Beliefs about Medicine Questionnaire (BMQ) toelichtingsformulier; 2011. Available from: https://meetinstrumentenzorg.nl/instrumenten/beliefs-about-medicine-questionnaire-bmq-bmq-specific-bmq-general/. Accessed July 6, 2022.
   Google Scholar
• Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33(2):363. doi:10.2307/2529786
   PubMed Web of Science ®Google Scholar
• Verduijn M, Leendertse A, Moeselaar A, de Wit N, van Marum R. Multidisciplinaire richtlijn polyfarmacie bij ouderen. Huisarts Wet. 2013;56(8):414–419. doi:10.1007/s12445-013-0215-y
   Google Scholar
• Ure J, Pinnock H, Hanley J, et al. Piloting tele-monitoring in COPD: a mixed methods exploration of issues in design and implementation. Prim Care Respir J. 2012;21(1):57–64. doi:10.4104/pcrj.2011.00065
   PubMedGoogle Scholar
• Pinnock H, Steed L, Jordan R. Supported self-management for COPD: making progress, but there are still challenges. Eur Respir J. 2016;48(1):6–9. doi:10.1183/13993003.00576-2016
   PubMed Web of Science ®Google Scholar
• Cravo A, Attar D, Freeman D, Holmes S, Ip L, Singh SJ. The importance of self-management in the context of personalized care in COPD. Int J Chron Obstruct Pulmon Dis. 2022;17:231–243. doi:10.2147/COPD.S343108
   PubMed Web of Science ®Google Scholar
• Bucknall CE, Miller G, Lloyd SM, et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ. 2012;344(mar061):e1060–e1060. doi:10.1136/bmj.e1060
   PubMed Web of Science ®Google Scholar
• Bischoff EWMA, Hamd DH, Sedeno M, et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax. 2011;66(1):26–31. doi:10.1136/thx.2009.127621
   PubMed Web of Science ®Google Scholar
• Yadav UN, Hosseinzadeh H, Lloyd J, Harris MF. How health literacy and patient activation play their own unique role in self-management of chronic obstructive pulmonary disease (COPD)? Chron Respir Dis. 2019;16:147997311881641. doi:10.1177/1479973118816418
   Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PMA, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.113662
   PubMed Web of Science ®Google Scholar
• Restrepo R, Alvarez M, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–384. doi:10.2147/COPD.S3036
   PubMedGoogle Scholar
• George M. Adherence in asthma and COPD: new strategies for an old problem. Respir Care. 2018;63(6):818–831. doi:10.4187/respcare.05905
   PubMed Web of Science ®Google Scholar
• Rand CS. Patient adherence with COPD therapy. Eur Respir Rev. 2005;14(96):97–101. doi:10.1183/09059180.05.00009604
   Google Scholar
• Humenberger M, Horner A, Labek A, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163. doi:10.1186/s12890-018-0724-3
   PubMed Web of Science ®Google Scholar
• Huurne KK, Movig K, van der Valk P, et al. Differences in adherence to common inhaled medications in COPD. J Chron Obstruct Pulmon Dis. 2015;12(6):643–648. doi:10.3109/15412555.2014.995292
   PubMed Web of Science ®Google Scholar
• Batterink J, Dahri K, Aulakh A, Rempel C. Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease. Can J Hosp Pharm. 2012;65:2. doi:10.4212/cjhp.v65i2.1118
   Google Scholar
• van der Molen T, van Boven JFM, Maguire T, Goyal P, Altman P. Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist. Br J Clin Pharmacol. 2017;83(1):192–201. doi:10.1111/bcp.13087
   PubMed Web of Science ®Google Scholar
• Fathima M, Bawa Z, Mitchell B, Foster J, Armour C, Saini B. COPD management in community pharmacy results in improved inhaler use, immunization rate, COPD action plan ownership, COPD knowledge, and reductions in exacerbation rates. Int J COPD. 2021;16:519–533. doi:10.2147/COPD.S288792
   Google Scholar